Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data

Dettagli Bibliografici
Autori principali:	Coleman, R, Stevens, R, Holman, R
Natura:	Conference item
Pubblicazione:	2004

Documenti analoghi

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
di: Price, H, et al.
Pubblicazione: (2007)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
di: Stevens, R, et al.
Pubblicazione: (2002)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
di: Stevens, R, et al.
Pubblicazione: (2005)

Performance of the UKPDS Risk Engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort
di: Simmons, R, et al.
Pubblicazione: (2008)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
di: Coleman, R, et al.
Pubblicazione: (2005)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
di: Stevens, R, et al.
Pubblicazione: (2004)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
di: Coleman, R, et al.
Pubblicazione: (2006)

Could non-HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine?
di: Stevens, R, et al.
Pubblicazione: (2004)

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes.
di: Coleman, R, et al.
Pubblicazione: (2007)

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in Type 2 diabetes
di: Coleman, R, et al.
Pubblicazione: (2007)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
di: Stevens, R, et al.
Pubblicazione: (2001)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
di: Holman, R, et al.
Pubblicazione: (2001)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
di: Coleman, R, et al.
Pubblicazione: (2007)

Cardiovascular Events in People with Type 2 Diabetes: Performance of Framingham, UKPDS, and ADVANCE Risk Equations
di: Elaheh Yaghoubvand, et al.
Pubblicazione: (2021-11-01)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
di: Adler, A, et al.
Pubblicazione: (2000)

Risk factors for neuropathy in UKPDS
di: Stratton, I, et al.
Pubblicazione: (2004)

Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
di: Leal, J, et al.
Pubblicazione: (2021)

Prediction of Coronary Heart Disease on Civil Servants in Jember by Framingham Risk Score
di: Muhammad Nadzir A. Akbar, et al.
Pubblicazione: (2023-02-01)

Framingham risk score and alternatives for prediction of coronary heart disease in older adults.
di: Nicolas Rodondi, et al.
Pubblicazione: (2012-01-01)

Adding multiple risk factors improves Framingham coronary heart disease risk scores
di: Hu G, et al.
Pubblicazione: (2014-09-01)

Ethnic differences in diabetic nephropathy - The UKPDS
di: Stevens, R, et al.
Pubblicazione: (1999)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
di: Stevens, R, et al.
Pubblicazione: (2002)

Assessment of Framingham risk score and systemic coronary risk evaluation in rosacea patients
di: Asli Akin Belli, et al.
Pubblicazione: (2017-09-01)

Prediction of risk factors for coronary heart disease using Framingham Risk Score in Korean men.
di: Jae-Hong Ryoo, et al.
Pubblicazione: (2012-01-01)

Comparative study of prognostic value for coronary disease risk between the U.K. Prospective diabetes study and framingham models: response to Protopsaltis et al.
di: Stevens, R, et al.
Pubblicazione: (2004)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
di: Stevens, R, et al.
Pubblicazione: (2000)

Coronary age as a risk factor in the modified Framingham risk score
di: Whitcomb Brian W, et al.
Pubblicazione: (2004-04-01)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
di: Alva, M, et al.
Pubblicazione: (2014)

Framingham score in the evaluation of cardiovascular risk in diabetics
di: Mariana Costa Larré, et al.
Pubblicazione: (2015-02-01)

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.
di: Simmons, R, et al.
Pubblicazione: (2009)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
di: Davis, T, et al.
Pubblicazione: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)
di: Davis, T, et al.
Pubblicazione: (2014)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
di: Holman, R
Pubblicazione: (2007)

Research inefficiencies in external validation studies of the Framingham Wilson coronary heart disease risk rule: A systematic review
di: Ban, J, et al.
Pubblicazione: (2024)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
di: Kohner, E, et al.
Pubblicazione: (2001)

UKPDS: what was the question? UK Prospective Diabetes Study.
di: Turner, R, et al.
Pubblicazione: (1999)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
di: Kothari, V, et al.
Pubblicazione: (2002)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
di: Wamil, M, et al.
Pubblicazione: (2021)

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.
di: Adler, A, et al.
Pubblicazione: (2002)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
di: Gray, A, et al.
Pubblicazione: (2001)